BIOMAT Database Logo BIOMAT Database Logo

Pharmacology and therapeutic applications of hirudin, a new anticoagulant. 1998

E Glusa
Klinikum der Friedrich-Schiller-Universität Jena, Zentrum für Vaskuläre Biologie und Medizin, Erfurt, Germany.

UI MeSH Term Description Entries
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D006629 Hirudins Single-chain polypeptides of about 65 amino acids (7 kDa) from LEECHES that have a neutral hydrophobic N terminus, an acidic hydrophilic C terminus, and a compact, hydrophobic core region. Recombinant hirudins lack tyr-63 sulfation and are referred to as 'desulfato-hirudins'. They form a stable non-covalent complex with ALPHA-THROMBIN, thereby abolishing its ability to cleave FIBRINOGEN. Hirudin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000991 Antithrombins Endogenous factors and drugs that directly inhibit the action of THROMBIN, usually by blocking its enzymatic activity. They are distinguished from INDIRECT THROMBIN INHIBITORS, such as HEPARIN, which act by enhancing the inhibitory effects of antithrombins. Antithrombin,Direct Antithrombin,Direct Antithrombins,Direct Thrombin Inhibitor,Direct Thrombin Inhibitors,Antithrombin, Direct,Antithrombins, Direct,Inhibitor, Direct Thrombin,Thrombin Inhibitor, Direct,Thrombin Inhibitors, Direct
D013923 Thromboembolism Obstruction of a blood vessel (embolism) by a blood clot (THROMBUS) in the blood stream. Thromboembolisms
D024764 Hirudin Therapy Use of HIRUDINS as an anticoagulant in the treatment of cardiological and hematological disorders.

Related Publications

E Glusa
The pharmacology of recombinant hirudin, a new anticoagulant.
September 1990, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
E Glusa
Hirudin and hirudin analogues as new anticoagulant agents.
September 1995, Current opinion in hematology,
E Glusa
[Hirudin. A new and promising anticoagulant from leech].
September 1991, La Revue du praticien,
E Glusa
Hirudin, a new therapeutic tool?
August 1991, Annals of hematology,
E Glusa
Recombinant hirudin: clinical pharmacology and potential applications in nephrology.
June 1999, BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy,
E Glusa
[New oral anticoagulant pharmacology].
September 2013, Presse medicale (Paris, France : 1983),
E Glusa
New therapeutic applications for the anticoagulant, activated protein C.
August 2008, Expert opinion on biological therapy,
E Glusa
[Chemistry, pharmacology and therapeutic applications of phenylacetylurea, a new anti-epileptic substance].
September 1952, Minerva medica,
E Glusa
A new therapeutic anticoagulant.
February 1969, The Veterinary record,
E Glusa
Development of recombinant hirudin as a therapeutic anticoagulant and antithrombotic agent: some objective considerations.
July 1989, Seminars in thrombosis and hemostasis,
Copied contents to your clipboard!